Scientus Pharma (HydRx Farms Ltd. d/b/a Scientus Pharma Inc.) is a vertically‑integrated biopharmaceutical Licensed Dealer under the Narcotics Control Regulations of Canada that conducts fundamental research on cannabinoids (genetic, biomolecular, etc.). The company focuses on developing and commercializing pharmaceutical‑grade cannabinoid derivative products and is one of a limited number of Licensed Dealers in Canada authorized to handle cannabinoid products. Scientus has the ability to wholesale, buy, process and sell cannabinoid derivatives to Licensed Producers and to international markets. Scientus is also a Licensed Producer (Cultivation) under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company completed a private placement offering that generated gross proceeds of approximately $15.8 million and intends to use net proceeds for working capital and general corporate purposes. The offering was arranged with GMP Securities L.P. acting as sole agent.

Total raised

$16M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2018